Your browser doesn't support javascript.
loading
What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM.
Bendenoun, M; Samri, A; Avettand-Fènoël, V; Cardinaud, S; Descours, B; Carcelain, G; Mazeron, M-C; Bergmann, J-F; Urrutia, A; Moris, A; Rouzioux, C; Simon, F; Andre, P; Pocard, M; Dray, X; Mourez, T; Vieillard, V; Autran, B; Barin, F; Sellier, P.
Affiliation
  • Bendenoun M; Département de Médecine Interne, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand Widal, APHP, Paris, France.
  • Samri A; U1135, CIMI, INSERM, Paris, France; Sorbonne Universités, UPMC Université Paris 06, Paris, France.
  • Avettand-Fènoël V; EA7327, Faculté de Médecine, Université Paris-Descartes, Sorbonne Paris Cité, France; Laboratoire de Virologie, Hôpital Necker-Enfants Malades, APHP, Paris, France.
  • Cardinaud S; U1135, CIMI, INSERM, Paris, France; Sorbonne Universités, UPMC Université Paris 06, Paris, France.
  • Descours B; U1135, CIMI, INSERM, Paris, France; Sorbonne Universités, UPMC Université Paris 06, Paris, France.
  • Carcelain G; U1135, CIMI, INSERM, Paris, France; Sorbonne Universités, UPMC Université Paris 06, Paris, France; Département d'Immunologie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
  • Mazeron MC; Laboratoire de Virologie, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand Widal, APHP, Paris, France.
  • Bergmann JF; Département de Médecine Interne, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand Widal, APHP, Paris, France.
  • Urrutia A; U1135, CIMI, INSERM, Paris, France; Sorbonne Universités, UPMC Université Paris 06, Paris, France.
  • Moris A; U1135, CIMI, INSERM, Paris, France; Sorbonne Universités, UPMC Université Paris 06, Paris, France; Département d'Immunologie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
  • Rouzioux C; EA7327, Faculté de Médecine, Université Paris-Descartes, Sorbonne Paris Cité, France; Laboratoire de Virologie, Hôpital Necker-Enfants Malades, APHP, Paris, France.
  • Simon F; Laboratoire de Virologie, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand Widal, APHP, Paris, France.
  • Andre P; CIRI, INSERM U1111, CNRS UMR5308, Université Lyon 1, ENS de Lyon, Lyon, France; Laboratoire de Virologie, Hôpital de la Croix-Rousse, Lyon, France.
  • Pocard M; Service de Chirurgie Digestive et Cancérologique, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand Widal, APHP, Paris, France; INSERMU 965, Angiogenèse et recherche translationnelle, Paris 7, France.
  • Dray X; Service de Gastroentérologie, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand Widal, APHP, Paris, France.
  • Mourez T; Normandie Univ, UNIROUEN, EA 2656, Rouen University Hospital, Department of Virology, F-76000 Rouen, France.
  • Vieillard V; U1135, CIMI, INSERM, Paris, France; Sorbonne Universités, UPMC Université Paris 06, Paris, France; CNRS ERL8255, Centre, d'Immunologie et de Maladies Infectieuses (CIMI-Paris), Paris, France.
  • Autran B; U1135, CIMI, INSERM, Paris, France; Sorbonne Universités, UPMC Université Paris 06, Paris, France; Département d'Immunologie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
  • Barin F; Inserm U966 & National Reference Center for HIV, Université François-Rabelais & CHU Bretonneau, Tours, France.
  • Sellier P; Département de Médecine Interne, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand Widal, APHP, Paris, France. Electronic address: pierre.sellier@aphp.fr.
EBioMedicine ; 27: 51-60, 2018 Jan.
Article in En | MEDLINE | ID: mdl-29273355
ABSTRACT

BACKGROUND:

We describe a homosexual man who strongly controlled HIV-1 for ten years despite lack of protective genetic background.

METHODS:

HIV-1 DNA was measured in blood and other tissues. Cell susceptibility was evaluated with various strains. HIV-1-specific (CD4 and CD8 activation markers and immune check points) and NK cells responses were assessed; KIRs haplotypes and HLA alleles were determined.

FINDINGS:

Two HIV-1 RNA copies/mL of plasma were detected in 2009, using an ultra-sensitive assay. HIV-DNA was detected at 1.1 and 2 copies/106 PBMCs in 2009 and 2015 respectively, at 1.2 copies/106 cells in rectal cells in 2011. WBs showed weak reactivity with antibodies to gp160, p55 and p25 from 2007 to 2014, remaining incomplete in 2017. CD4 T cells were susceptible to various strains including HIVKON, a primary isolate of his own CRF02_AG variant. CD8 T cells showed a strong poly-functional response against HIV-Gag, producing mainly IFN-γ; a robust capacity of antibody-dependant cell cytotoxicity (ADCC) was observed in NK cells. Case patient was group B KIR haplotype. Neutralizing antibodies were not detected. CD4 and CD8 blood T cells showed normal proportions without increased activation markers. Phylogenetic analyses identified the same CRF02_AG variant in his partner. The patient and his partner were heterozygous for the CCR5ΔD32 deletion and shared HLA-B*07, C*07 non-protective alleles.

INTERPRETATION:

This thorough description of the natural history of an individual controlling HIV-1 in various compartments for ten years despite lack of protective alleles, and of his partner, may have implications for strategies to cure HIV-1 infection.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sexual Partners / Homosexuality, Male / Genetic Background Type of study: Prognostic_studies Limits: Adult / Humans / Male Language: En Journal: EBioMedicine Year: 2018 Document type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sexual Partners / Homosexuality, Male / Genetic Background Type of study: Prognostic_studies Limits: Adult / Humans / Male Language: En Journal: EBioMedicine Year: 2018 Document type: Article Affiliation country: France
...